Lokhnygina Yuliya, Helterbrand Jeffrey D
Department of Biostatistics and Bioinformatics, Duke University, 2400 Pratt Street, Room 0311, Terrace Level, Durham, North Carolina 27705, USA.
Biometrics. 2007 Jun;63(2):422-8. doi: 10.1111/j.1541-0420.2007.00707.x. Epub 2007 Apr 9.
Two-stage randomization designs (TSRD) are becoming increasingly common in oncology and AIDS clinical trials as they make more efficient use of study participants to examine therapeutic regimens. In these designs patients are initially randomized to an induction treatment, followed by randomization to a maintenance treatment conditional on their induction response and consent to further study treatment. Broader acceptance of TSRDs in drug development may hinge on the ability to make appropriate intent-to-treat type inference within this design framework as to whether an experimental induction regimen is better than a standard induction regimen when maintenance treatment is fixed. Recently Lunceford, Davidian, and Tsiatis (2002, Biometrics 58, 48-57) introduced an inverse probability weighting based analytical framework for estimating survival distributions and mean restricted survival times, as well as for comparing treatment policies at landmarks in the TSRD setting. In practice Cox regression is widely used and in this article we extend the analytical framework of Lunceford et al. (2002) to derive a consistent estimator for the log hazard in the Cox model and a robust score test to compare treatment policies. Large sample properties of these methods are derived, illustrated via a simulation study, and applied to a TSRD clinical trial.
两阶段随机化设计(TSRD)在肿瘤学和艾滋病临床试验中越来越普遍,因为它们能更有效地利用研究参与者来检验治疗方案。在这些设计中,患者首先被随机分配到诱导治疗组,然后根据其诱导反应和对进一步研究治疗的同意情况,再随机分配到维持治疗组。在药物研发中,TSRD能否被更广泛接受可能取决于在这种设计框架内,当维持治疗固定时,能否对实验诱导方案是否优于标准诱导方案做出适当的意向性治疗类型推断。最近,Lunceford、Davidian和Tsiatis(2002年,《生物统计学》58卷,48 - 57页)引入了一种基于逆概率加权的分析框架,用于估计生存分布和平均受限生存时间,以及在TSRD环境下比较地标处的治疗策略。在实际应用中,Cox回归被广泛使用,在本文中,我们扩展了Lunceford等人(2002年)的分析框架,以推导Cox模型中对数风险的一致估计量和用于比较治疗策略的稳健得分检验。推导了这些方法的大样本性质,通过模拟研究进行了说明,并应用于一项TSRD临床试验。